Jeffrey T. L. Smith, Senior VP Translational Medicine at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 585 shares at $20.00 ($12K) on 2017-06-20, disclosed to the SEC on 2017-06-22.
Scheduled sale ($12k) by Senior VP Translational Medicine under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |